Charles Schwab’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30.9M | Sell |
654,174
-87,975
| -12% | -$4.52M | ﹤0.01% | 1549 |
|
|
2026
Q1 | $44M | Buy |
742,149
+3,495
| +0.5% | +$227K | 0.01% | 1246 |
|
|
2025
Q4 | $45.6M | Buy |
738,654
+35,126
| +5% | +$2.15M | 0.01% | 1220 |
|
|
2025
Q3 | $43.9M | Sell |
703,528
-4,559
| -0.6% | -$317K | 0.01% | 1242 |
|
|
2025
Q2 | $56.5M | Buy |
708,087
+65,697
| +10% | +$5.49M | 0.01% | 1021 |
|
|
2025
Q1 | $55.2M | Buy |
642,390
+6,370
| +1% | +$522K | 0.01% | 1007 |
|
|
2024
Q4 | $49.7M | Buy |
636,020
+33,844
| +6% | +$2.63M | 0.01% | 1131 |
|
|
2024
Q3 | $43.4M | Sell |
602,176
-63,650
| -10% | -$4.51M | 0.01% | 1215 |
|
|
2024
Q2 | $45.8M | Sell |
665,826
-22,900
| -3% | -$1.55M | 0.01% | 1146 |
|
|
2024
Q1 | $50M | Buy |
688,726
+31,591
| +5% | +$2.11M | 0.01% | 1041 |
|
|
2023
Q4 | $40.2M | Sell |
657,135
-39,913
| -6% | -$2.37M | 0.01% | 1142 |
|
|
2023
Q3 | $39.9M | Sell |
697,048
-10,064
| -1% | -$608K | 0.01% | 1048 |
|
|
2023
Q2 | $42M | Buy |
707,112
+53,140
| +8% | +$3.18M | 0.01% | 972 |
|
|
2023
Q1 | $41M | Buy |
653,972
+5,378
| +0.8% | +$336K | 0.01% | 968 |
|
|
2022
Q4 | $40.6M | Buy |
648,594
+4,611
| +0.7% | +$264K | 0.01% | 953 |
|
|
2022
Q3 | $32.1M | Sell |
643,983
-3,463
| -0.5% | -$192K | 0.01% | 1050 |
|
|
2022
Q2 | $38.1M | Buy |
647,446
+20,998
| +3% | +$1.16M | 0.01% | 934 |
|
|
2022
Q1 | $33.2M | Buy |
626,448
+24,389
| +4% | +$1.41M | 0.01% | 1157 |
|
|
2021
Q4 | $36.5M | Buy |
602,059
+16,066
| +3% | +$954K | 0.01% | 1118 |
|
|
2021
Q3 | $32.9M | Buy |
585,993
+56,170
| +11% | +$3.08M | 0.01% | 1157 |
|
|
2021
Q2 | $27.6M | Buy |
529,823
+20,702
| +4% | +$994K | 0.01% | 1321 |
|
|
2021
Q1 | $22.4M | Buy |
509,121
+11,058
| +2% | +$465K | 0.01% | 1433 |
|
|
2020
Q4 | $17.4M | Buy |
498,063
+5,100
| +1% | +$181K | 0.01% | 1502 |
|
|
2020
Q3 | $18M | Sell |
492,963
-15,875
| -3% | -$590K | 0.01% | 1282 |
|
|
2020
Q2 | $19.1M | Sell |
508,838
-14,361
| -3% | -$574K | 0.01% | 1215 |
|
|
2020
Q1 | $19.2M | Buy |
523,199
+14,410
| +3% | +$560K | 0.01% | 1046 |
|
|
2019
Q4 | $20.6M | Buy |
508,789
+19,311
| +4% | +$720K | 0.01% | 1186 |
|
|
2019
Q3 | $17M | Buy |
489,478
+13,019
| +3% | +$429K | 0.01% | 1253 |
|
|
2019
Q2 | $15.1M | Buy |
476,459
+7,388
| +2% | +$220K | 0.01% | 1334 |
|
|
2019
Q1 | $14M | Buy |
469,071
+33,642
| +8% | +$964K | 0.01% | 1365 |
|
|
2018
Q4 | $13.4M | Buy |
435,429
+3,097
| +0.7% | +$113K | 0.01% | 1251 |
|
|
2018
Q3 | $16.4M | Buy |
432,332
+20,753
| +5% | +$785K | 0.01% | 1289 |
|
|
2018
Q2 | $15.8M | Sell |
411,579
-11,335
| -3% | -$382K | 0.01% | 1264 |
|
|
2018
Q1 | $14.3M | Sell |
422,914
-98,051
| -19% | -$3.76M | 0.01% | 1244 |
|
|
2017
Q4 | $23.1M | Buy |
520,965
+39,436
| +8% | +$1.8M | 0.02% | 890 |
|
|
2017
Q3 | $24.1M | Sell |
481,529
-50,154
| -9% | -$2.56M | 0.02% | 788 |
|
|
2017
Q2 | $28.1M | Sell |
531,683
-54,442
| -9% | -$2.92M | 0.03% | 631 |
|
|
2017
Q1 | $32.6M | Sell |
586,125
-91,918
| -14% | -$5.07M | 0.03% | 539 |
|
|
2016
Q4 | $35.3M | Sell |
678,043
-41,641
| -6% | -$2.01M | 0.04% | 461 |
|
|
2016
Q3 | $34.7M | Buy |
719,684
+102,004
| +17% | +$5.16M | 0.04% | 449 |
|
|
2016
Q2 | $34.2M | Sell |
617,680
-3,527
| -0.6% | -$194K | 0.04% | 425 |
|
|
2016
Q1 | $33.2M | Sell |
621,207
-43,857
| -7% | -$2.16M | 0.04% | 409 |
|
|
2015
Q4 | $34.2M | Buy |
665,064
+140,946
| +27% | +$7M | 0.05% | 376 |
|
|
2015
Q3 | $23.7M | Buy |
524,118
+21,769
| +4% | +$1.03M | 0.03% | 491 |
|
|
2015
Q2 | $23.2M | Buy |
502,349
+202,679
| +68% | +$8.87M | 0.03% | 513 |
|
|
2015
Q1 | $12.9M | Buy |
299,670
+91,267
| +44% | +$3.48M | 0.02% | 825 |
|
|
2014
Q4 | $7.24M | Sell |
208,403
-11,705
| -5% | -$388K | 0.01% | 1148 |
|
|
2014
Q3 | $7.13M | Sell |
220,108
-16,692
| -7% | -$558K | 0.01% | 1077 |
|
|
2014
Q2 | $8.03M | Sell |
236,800
-43,012
| -15% | -$1.38M | 0.01% | 1009 |
|
|
2014
Q1 | $7.63M | Buy |
279,812
+83,465
| +43% | +$2.48M | 0.01% | 1000 |
|
|
2013
Q4 | $7.03M | Buy |
196,347
+44,589
| +29% | +$1.48M | 0.01% | 988 |
|
|
2013
Q3 | $4.75M | Buy |
151,758
+3,910
| +3% | +$128K | 0.01% | 1226 |
|
|
2013
Q2 | $4.38M | Buy |
+147,848
| New | +$4.17M | 0.01% | 1178 |
|
Other funds holding PBH
AI
BIP
Charles Schwab's PBH Position: Q2 2026 in Review
Charles Schwab reduced its Prestige Consumer Healthcare (PBH) stake by 12% in Q2 2026, selling an estimated $4.52M and leaving 654,174 shares worth $30.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1549.
Charles Schwab first reported a position in PBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $56.5M in Q2 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Charles Schwab held 654,174 shares of Prestige Consumer Healthcare worth $30.9M as of Q2 2026.
- Charles Schwab sold 87,975 Prestige Consumer Healthcare shares in Q2 2026, an estimated $4.52M.
- Prestige Consumer Healthcare made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #1549 holding.
- Charles Schwab first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Prestige Consumer Healthcare position peaked at $56.5M in Q2 2025.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.